Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

ClinicalTrials.gov ID: NCT03941483

Public ClinicalTrials.gov record NCT03941483. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 2:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Proof of Concept, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

Study identification

NCT ID
NCT03941483
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
351 participants

Conditions and interventions

Interventions

  • ASP1128 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
35 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2019
Primary completion
Jul 25, 2021
Completion
Oct 19, 2021
Last update posted
Dec 3, 2024

2019 – 2021

United States locations

U.S. sites
27
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Heart Center Research, LLC Huntsville Alabama 35801
Sarver Heart Center Tucson Arizona 85724
Morton Plant Hospital Clearwater Florida 33756
Health Park Medical Center Fort Myers Florida 33908
Shands Hospital Gainesville Florida 32610
Florida Hospital Pepin Heart Institute Tampa Florida 33613
Southern Illinois University Springfield Illinois 62794
Luthern Medical Group Fort Wayne Indiana 46804
IU Health - Methodist Indianapolis Indiana 46202
St. Vincent Heart Center Indianapolis Indiana 46290
Indiana University Health Ball Memorial Hospital Muncie Indiana 47303
MercyOne Iowa Heart Center Des Moines Iowa 50314
Delmarva Heart, LLC Salisbury Maryland 21804
Ascension Genesys Hospital Grand Blanc Michigan 48439
Mid Michigan Medical Center Midland Michigan 48670
Minneapolis Heart Institute Minneapolis Minnesota 55407
Baptist Medical Center Jackson Mississippi 39202
St. Luke's Hospital of Kansas City Kansas City Missouri 64111
Lourdes Cardiology Services Voorhees Township New Jersey 08035
Duke University Medical Center Durham North Carolina 27710
Moses H. Cone Memorial Hospital Greensboro North Carolina 27401
Fairview Hospital - Cleveland Clinic Cleveland Ohio 44111
ProMedica Toledo Hospital Toledo Ohio 43606
Vanderbilt University Nashville Tennessee 37232
Baylor Scott & White Heart Hospital Plano Texas 75093
University of Texas Health Science Center San Antonio Texas 78229
WVU Heart and Vascular Institute Morgantown West Virginia 26506

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03941483, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2024 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03941483 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →